What is Palbociclib?
Category: Prescription Drugs
Most popular types: Ibrance
Palbociclib is a medication that may be used as treatment of ER-positive and HER2-negative breast cancer.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Breast cancer | 13 | 9 | |
| Bone metastases | 7 | 3 | |
| Lung cancer | 2 | 0 | |
| Liver metastasis | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 6 | |
| Mild | 3 | |
| None | 1 |
Commonly reported side effects and conditions associated with Palbociclib
| Side effect | Patients | Percentage |
|---|---|---|
| Fatigue | 2 | |
| Hair loss | 2 | |
| Canker sores (aphthous ulcer) | 1 | |
| Constant tiredness | 1 | |
| Hot flashes at night | 1 | |
| Itchy skin | 1 |
Why patients stopped taking Palbociclib
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Doctor's advice | 1 |
Duration
Stopped taking Palbociclib
| Duration | Patients | Percentage |
|---|---|---|
| 1 - 2 years | 1 |
What people switch to and from
Patients started taking Palbociclib after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Exemestane (Aromasin) | 2 | |
| Carboplatin | 1 | |
| Chemotherapy | 1 | |
| Everolimus (Afinitor) | 1 |
Patients stopped taking Palbociclib and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Everolimus (Afinitor) | 1 | |
| Exemestane (Aromasin) | 1 |
Last updated: